Comparative Pharmacology

Head-to-head clinical analysis: DELFLEX W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DELFLEX W DEXTROSE 2 5 LOW MAGNESIUM IN PLASTIC CONTAINER.

Peer-Reviewed Evidence

Differential Analysis

DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

Peritoneal dialysis solution

Category C

DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER

Peritoneal dialysis solution

Category C

Head-to-Head

Clinical Matrix

Mechanism of Action

Delflex with Dextrose 2.5% is a peritoneal dialysis solution that provides osmotic ultrafiltration and electrolyte replacement. Dextrose creates an osmotic gradient across the peritoneal membrane, promoting fluid removal. The solution corrects electrolyte imbalances and removes metabolic waste products via diffusion and convection.

Intraperitoneal administration of dextrose and electrolytes creates an osmotic gradient that promotes ultrafiltration and removal of uremic toxins and excess fluid across the peritoneal membrane. Low magnesium formulation reduces magnesium load in patients with hypermagnesemia or renal impairment.

Clinical Dosing

Intraperitoneal administration: 2-3 L per exchange, 4 exchanges per day, with dwell times of 4-6 hours; typical total volume 8-12 L daily.

Intraperitoneal instillation of 2 L (or as prescribed) of 2.5% dextrose-containing peritoneal dialysis solution, typically exchanged 4 times daily. The volume and frequency are individualized based on patient's size, residual renal function, and ultrafiltration needs.

Direct Interaction

None Documented